The University of Greifswald, formerly also known as “Ernst-Moritz-Arndt University of Greifswald“, is a public research university located in Greifswald, Germany, in the state of Mecklenburg-Western Pomerania.

During the past decade, Ernst-Moritz-Arndt Universität Greifswald conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ernst-Moritz-Arndt Universität Greifswald" #1 sponsor was "Biotronik SE & Co. KG" with 4 trials, followed by "Celgene" with 3 trials sponsored, "Celgene Corporation" with 1 trials sponsored, "Center for Sepsis Control and Care, Germany" with 1 trials sponsored and "Ferrer Internacional S.A." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ernst-Moritz-Arndt Universität Greifswald" #1 collaborator was "IHF GmbH - Institut für Herzinfarktforschung" with 1 trials as a collaborator and "Qmed Consulting A/S" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Ernst-Moritz-Arndt Universität Greifswald" are "Acute Stroke" (1 trials), "Antimetabolites, Antineoplastic" (1 trials), "Arrhythmias, Cardiac" (1 trials), "Atrial Fibrillation (AF)" (1 trials) and "Cerebral Infarction" (1 trials). Many other conditions were trialed in "Ernst-Moritz-Arndt Universität Greifswald" in a lesser frequency.

Most popular intervention types in "Ernst-Moritz-Arndt Universität Greifswald" are "Drug" (5 trials), "Device" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Aspirin" (1 trials), "BIOMONITOR III and BIOMONITOR IIIm" (1 trials), "BioMonitor" (1 trials) and "Cardiac resynchronisation therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ernst-Moritz-Arndt Universität Greifswald" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Ernst-Moritz-Arndt Universität Greifswald". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Ernst-Moritz-Arndt Universität Greifswald, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ernst-Moritz-Arndt Universität Greifswald, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".